Torin 2

Drug / Medication

A catalytic (ATP competitive) inhibitor of mTOR that theoretically inhibits both mTORC1 and mTORC2, showing potential in mitochondrial disease models, but not yet tested for aging effects in mice lifespan studies.

Mentioned in 1 video

Videos Mentioning Torin 2

175 - The biology of aging, rapamycin, and other interventions that target the aging process

175 - The biology of aging, rapamycin, and other interventions that target the aging process

Peter Attia MD

A catalytic (ATP competitive) inhibitor of mTOR that theoretically inhibits both mTORC1 and mTORC2, showing potential in mitochondrial disease models, but not yet tested for aging effects in mice lifespan studies.